The memorandum released by NPPA is aimed at monitoring the prices of non scheduled formulations and to ensure that no manufacturer/ importer/ distributor is allowed to increase the MRP of a non scheduled drug more than 10% of MRP during preceding 12 months and where the increase is beyond 10%, it shall reduce the same to the level often percent of MRP for next 12 months.
In order to monitor the price movement of 19 medical devices out of 23 medical devices, NPPA has developed a format where each company has to give the information as per all the medical devices it is selling in the market with all necessary details.
Apart from catheters, heart valves, orthopaedic implants and intraocular lenses, the list of medical devices also includes internal prosthetic replacements, disposable hypodermic needles, bone cements, surgical dressings, umbilical tapes, scalp vein set, in vitro diagnostic services of HIV , HBsAg and HCV , and ablation devices among others.
Source: NPPA India
Attachment: Office Memorandum